UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms underlying trastuzumab activity are complex

Nature reviews cardiology, 2015-11, Vol.12 (11), p.669-669

2015

Volltextzugriff (PDF)

Technical and clinical study of x‐ray‐based surface echo probe tracking using an attached fiducial apparatus

Medical physics (Lancaster), 2021-05, Vol.48 (5), p.2528-2542

2021

Volltextzugriff (PDF)

Cardiotoxicity in patients receiving Trastuzumab (Herceptin) : Primary toxicity, synergistic or sequential stress, or surveillance artifact?

Seminars in oncology, 1999-08, Vol.26 (4), p.96-101

1999

Volltextzugriff (PDF)

Enigmas regarding the true extent and impact of tyrosine kinase inhibitor-related cardiotoxicity

Expert opinion on drug safety, 2013-09, Vol.12 (5), p.611-614

2013

Volltextzugriff (PDF)

Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6073-6075

2009

Volltextzugriff (PDF)

Desarrollo profesional y autoeficacia docente del profesor universitario, Universidad Nacional Hermilio Valdizán - Huánuco 2013

Revista de investigación en psicología, 2014-01, Vol.17 (1), p.81-91

Portocarrero Merino, Ewer

2014

Volltextzugriff (PDF)

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7811-7819

2005

Volltextzugriff (PDF)

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2827-2834

1995

Volltextzugriff (PDF)

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity

Journal of clinical oncology, 2005-05, Vol.23 (13), p.2900-2902

2005

Volltextzugriff (PDF)

Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation

Cancer, 2001-10, Vol.92 (7), p.1905-1912

2001

Volltextzugriff (PDF)

Classification of Left Ventricular Diastolic Function Using American Society of Echocardiography Guidelines: Agreement among Echocardiographers

Echocardiography (Mount Kisco, N.Y.), 2013-10, Vol.30 (9), p.1022-1031

2013

Volltextzugriff (PDF)

Post-TAVR Ventricular Septal Defect in the Presence of Subaortic Membrane

Echocardiography (Mount Kisco, N.Y.), 2015-03, Vol.32 (3), p.604-606

2015

Volltextzugriff (PDF)

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

European heart journal cardiovascular imaging, 2014-10, Vol.15 (10), p.1063-1093

2014

Volltextzugriff (PDF)

Cardiotoxicity in adults: An update

Progress in pediatric cardiology, 2014-09, Vol.36 (1), p.57-59

2014

Volltextzugriff (PDF)

AN UNUSUAL CASE OF FUNGAL ENDOCARDITIS: A TALE FROM ITALY TO THE HEART

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.3709-3709

2023

Volltextzugriff (PDF)

Ethical Challenges in Oncology: Patient Care, Research, Education, and Economics

1, 2017

Volltextzugriff (PDF)

199OLong-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials

Cancer, 2003-06, Vol.97 (11), p.2869-2879

2003

Volltextzugriff (PDF)

Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7820-7826

2005

Volltextzugriff (PDF)

Anthracycline cardiotoxicity: why are we still interested?

Oncology (Williston Park, N.Y.), 2009-03, Vol.23 (3), p.234

2009

Volltextzugriff (PDF)

Abstract P4-21-09: Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2 positive early breast cancer (BIG 1-06)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-21-09

2017

Volltextzugriff (PDF)

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

Cancer, 1989-01, Vol.63 (1), p.37-45

1989

Volltextzugriff (PDF)

Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management

Circulation (New York, N.Y.), 2004-06, Vol.109 (25), p.3122-3131

2004

Volltextzugriff (PDF)

Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2459-2464

2012

Volltextzugriff (PDF)

26 – 50 von 439

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(372)
Mit Volltextzugriff
(346)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(436)
Deutsch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms underlying trastuzumab activity are complex

Technical and clinical study of x‐ray‐based surface echo probe tracking using an attached fiducial apparatus

Cardiotoxicity in patients receiving Trastuzumab (Herceptin) : Primary toxicity, synergistic or sequential stress, or surveillance artifact?

Enigmas regarding the true extent and impact of tyrosine kinase inhibitor-related cardiotoxicity

Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data

Desarrollo profesional y autoeficacia docente del profesor universitario, Universidad Nacional Hermilio Valdizán - Huánuco 2013

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity

Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation

Classification of Left Ventricular Diastolic Function Using American Society of Echocardiography Guidelines: Agreement among Echocardiographers

Post-TAVR Ventricular Septal Defect in the Presence of Subaortic Membrane

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Cardiotoxicity in adults: An update

AN UNUSUAL CASE OF FUNGAL ENDOCARDITIS: A TALE FROM ITALY TO THE HEART

Ethical Challenges in Oncology: Patient Care, Research, Education, and Economics

199OLong-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial

Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials

Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment

Anthracycline cardiotoxicity: why are we still interested?

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Abstract P4-21-09: Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2 positive early breast cancer (BIG 1-06)

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management

Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis

Suchergebnisse filtern